Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzylguanidine (MIBG) therapy in metastatic paediatric paraganglioma: observation on false "reverse" discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy -- Basu and Nair 79 (944): e53 Figure 3 -- The British Journal of Radiology

TABLE OF CONTENTS

	Help viewing high resolution images
	Return to article

Click on image to view larger version.

Figure 3. Post¹³¹I-MIBG treatment scan showing focal concentration in the medial part of left supraorbital region, T4–T6 vertebrae, left shoulder, right 8th rib and right superolateral part of L3 vertebra.

Return to article

TABLE OF CONTENTS

BJR

ALL BIR JOURNALS